Approximately 50% of Wistar "BB" rats spontaneously develop overt diabetes mellitus characterized by loss of /3-cells and "insulitis." To define abnormalities of immunoregulation in these rats, we quantitated their major circulating lymphocyte subsets. Independent of the development of diabetes, we found the BB rats to have a markedly increased percentage of circulating B lymphocytes which is secondary to a severe T-cell lymphocytopenia, with the major circulating T-cell subset reacting with monoclonal antibody W3/25 markedly decreased. This lymphocytopenia is present in every animal studied and contrasted with studies of the nondiabetic Wistar strain from which the "BB" rats were developed. DIABETES 30:887-889, October 1981. T he spontaneously diabetic Wistar rat (the "BB rat") has become an important animal model of type I insulin-dependent diabetes mellitus.
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Approximately 50% of these nonobese outbred Wistar rats between 60 and 120 days of age develop severe hyperglycemia associated with /3-cell depletion, insulitis, and ketoacidosis. Of major importance is the finding of Like et al. that various immunosuppressive regimens (including administration of anti-lymphocyte globulin) can prevent the onset of overt diabetes in these animal. 3 - 4 It is postulated that the development of diabetes mellitus is secondary to inherited abnormalities of immunologic function. In this report we describe our findings that all BB rats, independent of the development of overt diabetes, have a specific deficiency of T-cells reacting with monoclonal antibody W3/25.
METHODS
Nineteen rats of the BB strain and 20 rats of the control, nondiabetic Wistar strain (male and female) were kindly provided by Dr. P. Thibert. Rats were screened for glucosuria using Testape (Eli Lilly and Company, Indianapolis, Indiana) approximately every 3 days, and plasma glucose was measured using a Beckman glucose analyzer (Beckman Instruments, Fullerton, California) at least once a week. The onset of diabetes was abrupt in the six animals that became diabetic. Plasma glucose at the time of diagnosis of diabetes ranged from 284 to 649 mg/dl. Approximately every 2 wk, animals were gently anesthetized with ether, and 1 ml of blood was withdrawn from a tail vein into heparinized tubes for determination of white blood count, differential and lymphocyte subsets. White blood count was determined using a Coulter Zf counter and differential using Wright's stained slides. Peripheral white blood cells were then applied to a Ficoll-Hypaque gradient (24:10 v,v; 9% Ficoll 400:34% Hypaque M) and the lymphocytes and monocytes present at the interface of the gradient were harvested. This lymphocyte fraction was then incubated at 37°C for 45 min to remove cytophilic immunoglobulin, and then reacted with rhodamine conjugated F (ab') 2 anti-rat antibody (Cappel) at 4°C for 45 min, followed by three washes with phosphatebuffered saline containing 1% bovine albumin. To determine the percentage of B lymphocytes, the number of cells with rim fluorescence was determined using a Leitz-diavert microscope equipped for epifluorescence. To quantitate Tcell subsets, the lymphocyte preparation was incubated with either monoclonal antibody supernatants W3/13 ("pan T marker") or 3/25 ("helper" T) followed by incubation with fluorescein conjugated F(ab') 2 anti-mouse antibody. To determine the percentage of T-cells, the number of cells with fluorescein rim fluorescence was determined using the fluorescein filter of the Leitz-diavert microscope with correction for B-cells.
RESULTS
Immunoglobulin molecules which function as antigen receptors are integral proteins of the plasma membrane of B lymphocytes. B lymphocytes can therefore be detected by their reaction with rhodamine-conjugated anti-rat anti- bodies which bind to cell surface immunoglobulin (slg). When we initially determined the percentage of slg-positive lymphocytes of BB rats, we were surprised to find it to be greater than 25% in every animal studied. We expected the percentage of B lymphocytes to be less than 15%, as is the case with a number of other rat strains and with the control, nondiabetic Wistar strain provided by Dr. P. Thibert, the strain from which the BB rat was derived. As is apparent from Figure 1 , the percentage of B lymphocytes is markedly elevated not only in the 6 BB rats that become diabetic but also in the 13 animals that did not become diabetic. Panel A of Figure 1 plots the mean percentage of B lymphocytes for all the animals, while panel B illustrates studies of three representative individual animals. From the earliest determina- tion of B lymphocytes to the latest (even after the development of overt diabetes), the percentage of B lymphocytes of BB rats for each animal was elevated.
This could be either because of an increase in B lymphocytes, or because of a decrease in non-B lymphocytes, primarily T lymphocytes. That the latter explanation is correct is shown by the data illustrated in Figure 2 and Table 1 -994 * In experiment 1, mean ± SEM of four control rats and five BB Wistar rats; experiment 2, mean ± SEM of five control rats and three BB Wistar rats. t P < 0.01 by Student's t test.
THE BB DIABETIC RAT: T-CELL LYMPHOCYTOPENIA (8953 vs. 2968, P < 0.01) in the BB rats. As shown in Table  1 , experiment 1, which lists the number of cells per mm 3 , abnormalities in total white blood cells, and in total lymphocytes results from marked non-B-cell lymphocytopenia. Since the number of monocytes are unchanged, this probably represents a severe T-cell lymphocytopenia.
To confirm the T-cell lymphocytopenia and to evaluate Tcell subsets of the BB rat, we studied the reaction of murine monoclonal antibody W3/13 (a rat "pan T" cell marker) and W3/25 (reacts with a subset of T-cells which mediates "help" for antibody reaponse and graft vs. host reactions). As shown in Table 1 , experiment 2, the non-B lymphocyte fraction was approximately 90% T-cells as indicated by reaction with antibody W3/13 for both control rat and BB Wistar rats. Contrasting with the similar percentage of cells positive for antibody W3/13, 84% of control rat T-cells (W3/13 positive) were positive for W3/25 while only 8% of BB Wistar T-cells were W3/25 positive.
DISCUSSION
Our findings indicate that in addition to their development of diabetes mellitus, BB rats exhibit severe non-B-cell lymphocytopenia. This severe non-B-cell lymphocytopenia is accounted for by a decrease in the W3/25 T-cell subset. This major T-cell subset, 5 made up of roughly 80% of control Wistar T-cells, comprises only approximately 8% of BB Tcells. W3/25 T-cell lymphocytopenia can account for all of the lymphocytopenia of the BB rat. The function of W3/25 cells has not been completely defined, but these cells are known to mediate "help" in the production of anti-hapten antibodies and graft vs. host reactions. Furthermore, antibody W3/25 is able to block the in vitro mixed lymphocyte reaction. 6 All BB rats we have studied express this severe T-cell lymphocytopenia, which is independent of the development of overt diabetes mellitus. It has been reported that some BB rats develop both abnormal glucose tolerance and insulitis in the absence of overt diabetes mellitus. 7 If all BB rats do not have some degree of islet cell pathology, then the abnormality of lymphocyte subsets we have discovered is either independent of the development of diabetes or, more likely, predisposes animals to the development of overt disease, with other factors (genetic or environmental) triggering severe /3-cell destruction.
The abnormalities of lymphocytes we find in the BB rat are not analogous to our studies to date in type I diabetes mellitus. 8 In this illness, a specific T-cell subset bearing the la antigen is markedly increased at the onset of diabetes without a T-cell lymphocytopenia.
8 T-cell lymphocytopenia is, however, a concomitant of other human autoimmune diseases, lupus erythemaosus in particular. 9 We have recently found that some patients with lupus erythematosus and other diseases characterized by polyclonal B lymphocyte activation have anti-islet antibodies reacting with sections of Bouin's fixed pancreas. 10 Similarly, autoimmune animal models which exhibit insulitis have been discovered. 11 It is possible that the BB rat is similar to these autoimmune mice, but with quantitatively greater /3-celI destruction. Studies to ascertain the mechanism of the lymphocytopenia of the BB rat, including characterization of minor T-cell subsets using other monoclonal antibodies, should help in defining the pathogenic significance of their severe lymphocytopenia.
